Boltz Raises $110M Series A as Token Usage Grows 50x
Boltz raised a $110M Series A led by Bessemer VP, with molecular token usage growing 50x since June and partnerships with 6 of the top 20 pharma companies. Its June-released BoltzMol-1 and BoltzProt-1 models enabled reliable hit discovery and protein design, and the new funds will go toward compute, data and model teams.
2026-11-18 ~ 2026-11-18 · 3 related posts
- Boltz raises $110M Series A for AI biomolecular design, partners with 6 top-20 pharma giants — GabriCorso · 2026-11-18
- BoltzMol-1 and BoltzProt-1 marked a step toward reliable hit discovery and binder design — GabriCorso · 2026-11-18
- Boltz: next-gen models show substantial quality gains; funding to fuel compute and data — GabriCorso · 2026-11-18